Skip to main content
Equibles

Pictet Asset Management Holding SA

Position in LLY — ELI LILLY & Co

CIK 1993888 CAROUGE, V8
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$905,551,734
+$37,310,929 QoQ
Shares Held
754,985
-20.0% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#89
of 4,632 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 51% Shared 0% None 49%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Pictet Asset Management Holding SA holds $3,393,842,702 across 13 Drug Manufacturers - General names. LLY ranks #1 (26.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		754,985 $905,551,734
2 AZN
Astrazeneca PLC
 2,937,510 $557,010,646
3 JNJ
Johnson & Johnson
 1,853,258 $470,671,934
4 GILD
Gilead Sciences, Inc.
 2,511,962 $317,361,279
5 AMGN
Amgen Inc
 872,311 $315,881,259
6 ABBV
AbbVie Inc.
 909,328 $228,823,297
7 MRK
Merck & Co., Inc.
 1,451,505 $186,518,392
8 BIIB
Biogen Inc.
 851,819 $184,044,013

All Filings in LLY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $905,551,734 754,985
2026-03-31 $868,240,805 943,976
2025-12-31 $946,262,276 880,506
2025-09-30 $526,759,940 690,380
2025-06-30 $557,770,085 715,521
2025-03-31 $575,340,468 696,614
2024-12-31 $511,349,640 662,370
2024-09-30 $550,693,216 621,592
2024-06-30 $556,719,067 614,901
2024-03-31 $517,555,783 665,273
2023-12-31 $373,942,597 641,499
2023-09-30 $339,409,761 631,895